A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here

Home: Drug Pipeline   Print This Page 


Cancer Consultants Cancer Drug Pipeline



Supportive Care - Nausea/Vomiting
Drug Name Class Developer Phase
597599 (vestipitant) NKI antagonist GlaxoSmithKline II
679769 (emitasol) NKI antagonist GlaxoSmithKline II
Metoclopramide Intra Nasal Spray Benzamide Questcor II
For more information contact us at clinicaltrials@cancerconsultants.com

View Drugs in Pipeline By Disease



© 1998-2007 CancerConsultants.com  All Rights Reserved.